Physicians

Next-Generation Prostate Cancer Radiotherapy

SpaceOAR hydrogel is the first absorbable hydrogel spacer designed to reduce unintentional rectal injury in men undergoing prostate radiotherapy (RT). Using ultrasound guidance, the hydrogel is administered as a liquid that expands the space between Denonvilliers’ fascia and the rectal wall, where it solidifies into a soft, but firm, hydrogel within 10 seconds. The hydrogel remains in place for 3 months during prostate radiotherapy, after which it liquefies by hydrolysis, and is absorbed and cleared in the patient’s urine.

Learn Why Radiation Oncologists & Urologists are Using SpaceOAR Hydrogel

ASTRO 2017 Industry Expert Theater: Present and Future Role of Hydrogel Spacing in the Treatment of Prostate Cancer

Watch Now

 

MRI image showing prostate and rectum before SpaceOAR hydrogel placement
MRI image of rectum and prostate with SpaceOAR Hydrogel spacer in place
MRI image showing prostate and rectum 6 months after treatment using SpaceOAR Hydrogel

Clinical Trial Patient, MRI Images

In order to assess SpaceOAR hydrogel safety and effectiveness a prospective, randomized, controlled, patient-blinded clinical study was performed. In 20 centers a total of 222 men were randomized to receive fiducial marker and SpaceOAR hydrogel injection, or fiducial markers alone (control group). Patients then received 79.2Gy x 44 fraction IG-IMRT, and were followed weekly during RT, and at 3, 6, 12 and 15 months.

SpaceOAR Hydrogel Clinical Trial Results

Prostate-Rectal Space Pre-implant: 1.6 mm
Post-implant: 12.6 mm
Procedure Success 99% Technical Success (gel present)
Rectal V70 Dose
(average)
Pre-SpaceOAR Hydrogel: 12.4%
Post-SpaceOAR Hydrogel: 3.3%
Acute Rectal Pain AE’s
(3 mo)
Control Group: 11.1%
SpaceOAR Hydrogel Group: 2.7%
Late Rectal Toxicity
(1 year post RT)
Control Group: 7% (Max G3*)
SpaceOAR Hydrogel Group: 2% (Max G1)
Bowel QOL (EPIC)
% Patients with >10pt decline (15 mo)
Control Group: 21.4%
SpaceOAR Hydrogel Group: 11.6%

* Key:
Grade 1 (G1): Mild, transient
Grade 2 (G2):Moderate, requiring prescription medication
Grade 3 (G3): Additional procedure required for treatment

Reference: http://www.redjournal.org/article/S0360-3016(15)00430-7/pdf

Please see Instructions for Use for a complete list of potential risks, warnings and precautions.

Request To Talk To a Representative About SpaceOAR Hydrogel